Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Myeloma Refractory

Clinical trial condition

Multiple Myeloma Refractory

Explore clinical trials studying Multiple Myeloma Refractory. Study availability and eligibility vary by location and protocol.

13 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma Refractory trial results

Not yet recruiting

Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial.

NCT07421856

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma

NCT06880601

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

NCT07210047

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Far Eastern Memorial Hospital Taipei, Taiwan

View Trial Details